MEDNAX (MD) Misses Q2 EPS by 4c

MEDNAX (NYSE: MD) reported Q2 EPS of $1.03, $0.04 worse than the analyst estimate of $1.07. Revenue for the quarter came in at $772 million versus the consensus estimate of $775.68 million.

For earnings history and earnings-related data on MEDNAX (MD) click here.

You May Also Be Interested In

• Jefferies Downgrades Pediatrix Medical Group (MD) to Hold
• Kingsoft Cloud Holdings Limited (KC) Tops Q2 EPS by 40c
• Corporación América Airports S.A. (CAAP) Misses Q2 EPS by 18c